{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Olema Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"OLMA"},"Address":{"label":"Address","value":"512, 2ND STREET, 4TH FLOOR, SAN FRANCISCO, California, 94107, United States"},"Phone":{"label":"Phone","value":"+1 650 243-5555"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250."},"CompanyUrl":{"label":"Company Url","value":"https://www.olema.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Kristin Lanzi","title":"Vice President-Information Technology"},{"name":"Mark Shilkrut","title":"Vice President-Clinical Development"},{"name":"Naseem Zojwalla","title":"Chief Medical Officer"},{"name":"Richard Hernandez","title":"Vice President-Clinical Development Operations"},{"name":"Sean P. Bohen","title":"President, Chief Executive Officer & Director"},{"name":"Shane William Charles Kovacs","title":"Chief Operating & Financial Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}